Carcinome urothélial : des classifications histologiques et moléculaires vers un traitement adéquat

Moch, 2016 Farrow, 1976, Morphological and clinical observations of patients with early bladder cancer treated with total cystectomy, Cancer Res, 36, 2495 Amin, 1997, Urothelial transitional cell carcinoma with endophytic growth patterns: a discussion of patterns of invasion and problems associated with assessment of invasion in 18 cases, Am J Surg Pathol, 21, 1057, 10.1097/00000478-199709000-00010 Chang, 2012, Prognostic significance in substaging of T1 urinary bladder urothelial carcinoma on transurethral resection, Am J Surg Pathol, 36, 454, 10.1097/PAS.0b013e31823dafd3 van Rhijn, 2012, A new and highly prognostic system to discern T1 bladder cancer substage, Eur Urol, 61, 378, 10.1016/j.eururo.2011.10.026 Keck, 2013, Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy, BMC Cancer, 13, 71, 10.1186/1471-2407-13-71 Cancer Genome Atlas Research Network, 2014, Comprehensive molecular characterization of urothelial bladder carcinoma, Nature, 507, 315, 10.1038/nature12965 Sjödahl, 2012, A molecular taxonomy for urothelial carcinoma, Clin Cancer Res, 18, 3377, 10.1158/1078-0432.CCR-12-0077-T Patschan, 2015, A molecular pathologic framework for risk stratification of stage T1 urothelial carcinoma, Eur Urol, 68, 824, 10.1016/j.eururo.2015.02.021 Choi, 2014, Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy, Cancer Cell, 25, 152, 10.1016/j.ccr.2014.01.009